Brings 30-years of Experience to Company’s Technology Development and Manufacturing Operations AUSTIN, Texas–(BUSINESS WIRE)–Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack...
Sachs Immuno-Oncology BD&L and Investment Forum and 2018 BIO International Convention AUSTIN, Texas & HAMILTON, Ontario – Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack...
Innovative immuno-therapy company welcomes proven leaders in pharma and therapeutics AUSTIN, Texas & HAMILTON, Ontario – Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers,...
AUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics, a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack multiple cancers, today announced a strategic relationship with the...
International Society for Cellular Therapy and Bloom Burton & Co. Healthcare Investor Conference AUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics, Inc., a privately held biopharmaceutical company developing a novel platform...
Innovative immuno-therapy company welcomes a recognized leader in life sciences and therapeutics AUSTIN, Texas & TORONTO–(BUSINESS WIRE)–Triumvira Immunologics, a privately-held biopharmaceutical company developing a novel platform for engineering T...
